A novel inhaled c-kit/pdgfr inhibitor for the treatment of asthma
Ended Project Grant Awarded Last action
- Award ID
- R43HL132709
- Recipient
-
Pulmokine, Inc. UEI CJAVXCPZUUM9
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $337,324
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Rensselaer, NY 12144, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $337,324 |
Quick answers
Who received award R43HL132709?
R43HL132709 was awarded to Pulmokine, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on April 7, 2016.
How much is award R43HL132709 worth?
$337,324 has been obligated on R43HL132709.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award